Show simple item record

Interaction of fatty acids with recombinant rat intestinal and liver fatty acid-binding proteins

dc.contributor.authorNemecz, Gyorgyen_US
dc.contributor.authorHubbell, Timothyen_US
dc.contributor.authorJefferson, John R.en_US
dc.contributor.authorLowe, John B.en_US
dc.contributor.authorSchroeder, Friedhelmen_US
dc.date.accessioned2006-04-10T14:46:04Z
dc.date.available2006-04-10T14:46:04Z
dc.date.issued1991-04en_US
dc.identifier.citationNemecz, Gyorgy, Hubbell, Timothy, Jefferson, John R., Lowe, John B., Schroeder, Friedhelm (1991/04)."Interaction of fatty acids with recombinant rat intestinal and liver fatty acid-binding proteins." Archives of Biochemistry and Biophysics 286(1): 300-309. <http://hdl.handle.net/2027.42/29398>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WB5-4DN49HT-23K/2/31b7b5533b41f303e8694f375f611458en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/29398
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1897956&dopt=citationen_US
dc.description.abstractIntestinal enterocytes contain two homologous fatty acid-binding proteins, intestinal fatty acid-binding protein (I-FABP)2 and liver fatty acid-binding protein (L-FABP). Since the functional basis for this multiplicity is not known, the fatty acid-binding specificity of recombinant forms of both rat I-FABP and rat L-FABP was examined. A systematic comparative analysis of the 18 carbon chain length fatty acid binding parameters, using both radiolabeled (stearic, oleic, and linoleic) and fluorescent (trans-parinaric and cis-parinaric) fatty acids, was undertaken. Results obtained with a classical Lipidex-1000 binding assay, which requires separation of bound from free fatty acid, were confirmed with a fluorescent fatty acid-binding assay not requiring separation of bound and unbound ligand. Depending on the nature of the fatty acid ligand, I-FABP bound fatty acid had dissociation constants between 0.2 and 3.1 [mu] and a consistent 1:1 molar ratio. The dissociation constants for L-FABP bound fatty acids ranged between 0.9 and 2.6 [mu] and the protein bound up to 2 mol fatty acid per mole of protein. Both fatty acid-binding proteins exhibited relatively higher affinity for unsaturated fatty acids as compared to saturated fatty acids of the same chain length. cis-Parinaric acid or trans-parinaric acid (each containing four double bonds) bound to L-FABP and I-FABP were displaced in a competitive manner by nonfluorescent fatty acid. Hill plots of the binding of cis- and trans- parinaric acid to L-FABP showed that the binding affinities of the two sites were very similar and did not exhibit cooperativity. The lack of fluorescence self-quenching upon binding 2 mol of either trans- or cis- parinaric acid/mol L-FABP is consistent with the presence of two binding sites with dissimilar orientation in the L-FABP. Thus, the difference in binding capacity between I-FABP and L-FABP predicts a structurally different binding site or sites.en_US
dc.format.extent1148812 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleInteraction of fatty acids with recombinant rat intestinal and liver fatty acid-binding proteinsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology and Laboratory Medicine and Howard Hughes Medical Institute, Medical Center, University of Michigan, Ann Arbor, Michigan 48105, USAen_US
dc.contributor.affiliationotherDivision of Pharmacology and Medicinal Chemistry, Department of Pharmacology and Cell Biophysics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0004, USAen_US
dc.contributor.affiliationotherDivision of Pharmacology and Medicinal Chemistry, Department of Pharmacology and Cell Biophysics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0004, USAen_US
dc.contributor.affiliationotherDivision of Pharmacology and Medicinal Chemistry, Department of Pharmacology and Cell Biophysics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0004, USAen_US
dc.contributor.affiliationotherDivision of Pharmacology and Medicinal Chemistry, Department of Pharmacology and Cell Biophysics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0004, USAen_US
dc.identifier.pmid1897956en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/29398/1/0000471.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0003-9861(91)90044-Jen_US
dc.identifier.sourceArchives of Biochemistry and Biophysicsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.